Almost 50 years of experience in the market allows JSC Olainfarm to focus on solving urgent medical problems, striving to improve the health condition and quality of life of people.

The company’s product range, which is constantly being developed and expanded, includes 60 finished dosage forms, 25 active pharmaceutical ingredients and more than 20 intermediates, including medicines for the nervous system, cardiovascular health, as well as antiviral, antibacterial and anti-allergic products.

The healthcare products created by Olainfarm provide both increasing user access to the medicines they need and the company’s growth and reputation in the global market.



Consolidated sales of the company Group in 2020 – 122 157 thousand euros, consolidated profit after taxes – 9 478 thousand euros.

Olainfarm products are exported to almost 60 countries around the world – about 75% of the production is sold in export markets. Major export markets: Russia, Ukraine, Belarus, the Netherlands, Kazakhstan, Uzbekistan and Germany. The further export market is Australia.

Olainfarm employs more than 1,000 professionals.

Olainfarm cooperates with such globally and regionally recognized companies as Novartis, Dr. Reddy’s, Glenmark Generics, Sigma AU, Almirall Ranke, UQUIFA, MIAT, Actavis, Teva, Egis and PHF.

Since 2011, JSC Olainfarm has been supplying an anti-tuberculosis product to the World Health Organization.

The company is particularly experienced in the development and manufacture of adamantan, quinuclidine, and the nitrofuran group of products.



The Olainfarm Group includes the Latvian green pharmaceutical company SIA Silvanols, the pharmacy network SIA Latvijas aptieka, the manufacturer of elastic medical products SIA Tonus Elast, medical institutions SIA Klīnika DiaMed and SIA Olainmed .


Olainfarm’s subsidiaries are located in Latvia, Belarus, Russia, Lithuania, Turkey, Azerbaijan, Estonia, the Czech Republic and Kyrgyzstan, representative offices in Russia, Ukraine, Belarus, Tajikistan, Kazakhstan, Albania, Armenia, Georgia, Kosovo, Mongolia and Uzbekistan, and representatives in the USA, India, Turkmenistan, Moldova, Sweden and Southeast Asia.



JSC Olainfarm is provided with modern technologies and certified according to:

  European Union Good Manufacturing Practice requirements;

  Russian Good Manufacturing Practice requirements;

  Environmental management standard ISO 14001: 2015;

  Laboratory standard ISO 17025;

  Partly – US Food and Drug Administration (FDA) standards;

  Partly – Australian Inspection Standards (TGA).